BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Furutani Y, Toguchi M, Shiozaki-Sato Y, Qin XY, Ebisui E, Higuchi S, Sudoh M, Suzuki H, Takahashi N, Watashi K, Wakita T, Kakeya H, Kojima S. An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes. PLoS One 2019;14:e0216139. [PMID: 31188831 DOI: 10.1371/journal.pone.0216139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kitamura H, Tanigawa T, Kuzumoto T, Nadatani Y, Otani K, Fukunaga S, Hosomi S, Tanaka F, Kamata N, Nagami Y, Taira K, Uematsu S, Watanabe T, Fujiwara Y. Interferon-α exerts proinflammatory properties in experimental radiation-induced esophagitis: Possible involvement of plasmacytoid dendritic cells. Life Sci 2022;289:120215. [PMID: 34890590 DOI: 10.1016/j.lfs.2021.120215] [Reference Citation Analysis]
2 Zhao YZ, You J, Liu HE. Suppressor of cytokine signaling proteins 1 and 3 and hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2020; 28(21): 1076-1083 [DOI: 10.11569/wcjd.v28.i21.1076] [Reference Citation Analysis]
3 Ye J, Chen J. Interferon and Hepatitis B: Current and Future Perspectives. Front Immunol 2021;12:733364. [PMID: 34557195 DOI: 10.3389/fimmu.2021.733364] [Reference Citation Analysis]
4 Yan Y, Qiu Y, Davgadorj C, Zheng C. Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection. Front Cell Infect Microbiol 2022;12:847539. [DOI: 10.3389/fcimb.2022.847539] [Reference Citation Analysis]
5 Wang BX, Fish EN. Global virus outbreaks: Interferons as 1st responders. Semin Immunol 2019;43:101300. [PMID: 31771760 DOI: 10.1016/j.smim.2019.101300] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 30.5] [Reference Citation Analysis]
6 Zeng J, Wu D, Hu H, Young JAT, Yan Z, Gao L. Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human Hepatocytes. Hepatology 2020;72:1935-48. [PMID: 32145089 DOI: 10.1002/hep.31217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Furutani Y, Toguchi M, Higuchi S, Yanaka K, Gailhouste L, Qin XY, Masaki T, Ochi S, Matsuura T. Establishment of a Rapid Detection System for ISG20-Dependent SARS-CoV-2 Subreplicon RNA Degradation Induced by Interferon-α. Int J Mol Sci 2021;22:11641. [PMID: 34769072 DOI: 10.3390/ijms222111641] [Reference Citation Analysis]
8 Qin Y, Bollin K, de Macedo MP, Carapeto F, Kim KB, Roszik J, Wani KM, Reuben A, Reddy ST, Williams MD, Tetzlaff MT, Wang WL, Gombos DS, Esmaeli B, Lazar AJ, Hwu P, Patel SP. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. J Immunother Cancer 2020;8:e000960. [PMID: 33203661 DOI: 10.1136/jitc-2020-000960] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
9 Zhang Y, Chen X, Cao Y, Yang Z. Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis. Bioengineered 2021;12:2074-86. [PMID: 34043485 DOI: 10.1080/21655979.2021.1931640] [Reference Citation Analysis]
10 Li J, Wen JX, Lu XC, Hou GQ, Gao X, Li Y, Liu L. Catalyst-Free Visible-Light-Promoted Cyclization of Aldehydes: Access to 2,5-Disubstituted 1,3,4-Oxadiazole Derivatives. ACS Omega 2021;6:26699-706. [PMID: 34661023 DOI: 10.1021/acsomega.1c04098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Park YK, Lee SY, Lee AR, Kim KC, Kim K, Kim KH, Choi BS. Antiviral activity of interferon-stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter. J Gastroenterol Hepatol. 2020;35:1426-1436. [PMID: 31951295 DOI: 10.1111/jgh.14986] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Gailhouste L, Sudoh M, Qin XY, Watashi K, Wakita T, Ochiya T, Matsuura T, Kojima S, Furutani Y. Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells. Cell Death Discov 2021;7:130. [PMID: 34078875 DOI: 10.1038/s41420-021-00515-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Fernandes RS, de Godoy AS, Santos IA, Noske GD, de Oliveira KIZ, Gawriljuk VO, Gomes Jardim AC, Oliva G. Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening. Virus Res 2021;299:198388. [PMID: 33887282 DOI: 10.1016/j.virusres.2021.198388] [Reference Citation Analysis]